PapersPMID:22610853
Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial.
- 01 · findings
- 7
- 02 · compound
- 1
- 03 · endpoints
- 7
- 04 · null
- 6
curcumin- Dose studied, every finding
- 1 g/day for 30 days
- Population, every finding
- obese individuals
What moved
1 findingHow to read these marks →curcumin — decreases triglycerides
very limitedFindingreplicated ×4
“As for the lipid profile parameters, serum triglycerides were significantly reduced following curcumin supplementation (p = 0.009).”
Quoted verbatim from Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial. - Study
- crossover
- Duration
- 4 weeks
What did not
6 findingscurcumin — no detected effect on C-reactive protein concentration
very limitedFindingNull resultreplicated ×3
“However, curcuminoids were not found to affect serum levels of total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and high-sensitivity C-reactive protein (p > 0.05).”
Quoted verbatim from Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial. - Study
- crossover
- Duration
- 4 weeks
curcumin — no detected effect on HDL cholesterol
very limitedFindingNull resultreplicated ×8
“However, curcuminoids were not found to affect serum levels of total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and high-sensitivity C-reactive protein (p > 0.05).”
Quoted verbatim from Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial. - Study
- crossover
- Duration
- 4 weeks
curcumin — no detected effect on body mass index
very limitedFindingNull resultreplicated ×3
“Anthropometric parameters including weight, BMI, waist circumference, hip circumference, arm circumference, and body fat remained statistically unchanged by the end of trial (p > 0.05).”
Quoted verbatim from Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial. - Study
- crossover
- Duration
- 4 weeks
curcumin — no detected effect on LDL cholesterol
very limitedFindingNull resultreplicated ×4
“However, curcuminoids were not found to affect serum levels of total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and high-sensitivity C-reactive protein (p > 0.05).”
Quoted verbatim from Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial. - Study
- crossover
- Duration
- 4 weeks
“Anthropometric parameters including weight, BMI, waist circumference, hip circumference, arm circumference, and body fat remained statistically unchanged by the end of trial (p > 0.05).”
Quoted verbatim from Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial. - Study
- crossover
- Duration
- 4 weeks
curcumin — no detected effect on total cholesterol (TC)
very limitedFindingNull resultreplicated ×3
“However, curcuminoids were not found to affect serum levels of total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and high-sensitivity C-reactive protein (p > 0.05).”
Quoted verbatim from Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial. - Study
- crossover
- Duration
- 4 weeks
Study record
- Read under
- curcumin
- Design
- crossover trial
- Species
- human
- Population
- obese individuals
- Participants
- 30
- Comparator
- placebo
- Duration
- 30 days
- Endpoints measured
- 3
- Record
- extracted
- Readings recorded
- 2